Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.
Press releases published on July 8, 2025
Two Days, Two Artists, One Powerful Mission: Cancer Can Rock Comes to Phoenix, Amplifying Hope Through Music
EIN Presswire
·
July 8, 2025
Nonprofit empowers musicians facing cancer with professional recording experiences PHOENIX, AZ, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- For the first time, the healing power of music is hitting Phoenix in stereo. Cancer Can Rock, a national …
Scottsdale Dentist Discusses Advantages of CEREC® Same-Day Crowns
EIN Presswire
·
July 8, 2025
Cosmetic dentist Todd Mabry, DDS details CEREC® technology and the benefits of same-day dental crowns. SCOTTSDALE, AZ, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- When combining CEREC® technology with dental crowns, patients can restore their …
Ardmore Institute of Health Supports The Institute for Functional Medicine in Helping Clinicians Address Chronic Disease
GlobeNewswire
·
July 8, 2025
Washington State, USA, July 08, 2025 (GLOBE NEWSWIRE) -- FEDERAL WAY, Wash. – July 8, 2025 – The Institute for Functional Medicine (IFM) today announced that Ardmore Institute of Health (AIH) has awarded it a $30,000 grant to accelerate the adoption of …
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
GlobeNewswire
·
July 8, 2025
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases …
AJA Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
July 8, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts
GlobeNewswire
·
July 8, 2025
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for …
Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate Arranged by CEO, John Mazarakis
GlobeNewswire
·
July 8, 2025
-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% -- -- Company also complies expansion of its consolidated credit facilities with an …
Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock
GlobeNewswire
·
July 8, 2025
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an …
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
GlobeNewswire
·
July 8, 2025
TORONTO and HAIFA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical results demonstrating that 100% of small animals treated with a …
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager …
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
GlobeNewswire
·
July 8, 2025
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to …
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
GlobeNewswire
·
July 8, 2025
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 …
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
GlobeNewswire
·
July 8, 2025
- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA - - Solid expects to initiate Phase …
RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance
GlobeNewswire
·
July 8, 2025
ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary …
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
GlobeNewswire
·
July 8, 2025
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering with accredited investors for the …
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
GlobeNewswire
·
July 8, 2025
BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market close. The company has scheduled a …
Rhythm Pharmaceuticals To Announce Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Acquired Hypothalamic Obesity
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the Company …
Health Care Cuts Will Impact Asthma Care
GlobeNewswire
·
July 8, 2025
Washington, DC, July 08, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement after Congress passed and the President signed H.R. 1, the so-called “Big, Beautiful Bill.” Kenneth Mendez, President and …
Market Barriers Continue to Challenge PNH Treatment Optimization Despite Emerging Options, According to Spherix Global Insights
GlobeNewswire
·
July 8, 2025
EXTON, PA, July 08, 2025 (GLOBE NEWSWIRE) -- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, chronic blood disorder that can affect individuals of any age, race, or gender, though it is most commonly diagnosed in adults in their 30s and 40s. In the …